Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 22 (12), 2313-2321
- https://doi.org/10.1681/asn.2011040361
Abstract
Time of ingestion of hypertension medications can affect circadian patterns of BP, but whether this translates into an effect on clinical outcomes is unknown. Here, in an open-label trial, we randomly assigned 661 patients with CKD either to take all prescribed hypertension medications upon awakening or to take at least one of them at bedtime. We measured 48-hour ambulatory BP at baseline and 3 months after any adjustment in treatment or, at the least, annually. After a median follow-up of 5.4 years, patients who took at least one BP-lowering medication at bedtime had an adjusted risk for total cardiovascular events (a composite of death, myocardial infarction, angina pectoris, revascularization, heart failure, arterial occlusion of lower extremities, occlusion of the retinal artery, and stroke) that was approximately one-third that of patients who took all medications upon awakening (adjusted HR 0.31; 95% CI 0.21 to 0.46; P < 0.001). Bedtime dosing demonstrated a similar significant reduction in risk for a composite outcome of cardiovascular death, myocardial infarction, and stroke (adjusted HR 0.28; 95% CI 0.13 to 0.61; P < 0.001). Furthermore, patients on bedtime treatment had a significantly lower mean sleep-time BP and a greater proportion demonstrated control of their ambulatory BP (56% versus 45%, P = 0.003). Each 5-mmHg decrease in mean sleep-time systolic BP was associated with a 14% reduction in the risk for cardiovascular events during follow-up (P < 0.001). In conclusion, among patients with CKD and hypertension, taking at least one antihypertensive medication at bedtime improves control of BP and reduces the risk for cardiovascular events.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populationsJournal Of Hypertension, 2010
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney DiseaseHypertension, 2009
- Chronotherapy Improves Blood Pressure Control and Reverts the Nondipper Pattern in Patients With Resistant HypertensionHypertension, 2008
- Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in HypertensionHypertension, 2008
- Predictors of All-Cause Mortality in Clinical Ambulatory MonitoringHypertension, 2007
- Decrease in Urinary Albumin Excretion Associated With the Normalization of Nocturnal Blood Pressure in Hypertensive SubjectsHypertension, 2005
- Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular MortalityHypertension, 2005
- J-Shaped Relation Between Blood Pressure and Stroke in Treated HypertensivesHypertension, 1999